Logo image
Abstract 039: Safety of Adjunct Emergent Stenting in Medium Vessel Occlusion
Abstract   Open access   Peer reviewed

Abstract 039: Safety of Adjunct Emergent Stenting in Medium Vessel Occlusion

A Abu Qdais, E Almallouhi, J Burkhardt, R Grandhi, B Jankowitz, M Ezzeldin, S Yaghi, K Moldovan, H Al-Jehani, M Psychogios, …
Stroke: vascular and interventional neurology, Vol.4(S1)
11/01/2024
DOI: 10.1161/SVIN.04.suppl_1.039
PMCID: PMC12773861
url
https://doi.org/10.1161/SVIN.04.suppl_1.039View
Published (Version of record) Open Access

Abstract

IntroductionMechanical thrombectomy (MT) can be complicated by underlying intracranial atherosclerotic stenosis (ICAS), resulting in failed reperfusion or re‐occlusion requiring rescue adjunct stenting. This secondary analysis aims to describe the safety of rescue stenting in the MeVO population.MethodsWe conducted a secondary analysis of the RESCUE‐ICAS multicenter observational cohort study, focusing on patients with MeVO who underwent mechanical thrombectomy with or without adjunct emergent intracranial stenting. MeVO was defined as occlusion in the M2 or M3 segments of the middle cerebral artery, anterior cerebral artery, or posterior cerebral artery. The primary safety outcomes assessed were rates of symptomatic intracranial hemorrhage (sICH) and procedural complications.ResultsOf the 417 patients included in the primary study, 51 patients had medium vessel occlusion; 20 received adjunct stenting, and 31 underwent MT alone. Median age was 73 years and 24 (47.1%) were females. Median admission NIHSS was 13 and 17 (33.3%) received IV thrombolytics. General anesthesia was used in 31 (60.8%) and aspiration was used first in 25 (49%). In the overall MeVO cohort, 2 (3.9%) patients had symptomatic intracranial hemorrhage (1 patient in the stenting group and 1 in the MT alone group), and 2 (3.9%) patients had periprocedural complications (both in the MT alone group).ConclusionThis descriptive secondary analysis suggests that adjunct emergent stenting appears to be a safe intervention in MeVO patients with underlying ICAS, with low rates of symptomatic intracranial hemorrhage and procedural complications compared to MT alone. However, larger‐scale prospective studies are warranted to further validate the overall safety of this procedure in the MeVO population.Table 1. Demographics and outcomes in MeVO population
Hemorrhage Veins & arteries

Details

Metrics

14 Record Views
Logo image